Are high urea values before intravenous immunoglobulin replacement a risk factor for COVID-related mortality?
View ORCID ProfileGökhan Aytekіn, Emel Atayik
doi: https://doi.org/10.1101/2022.01.29.22270080
Gökhan Aytekіn
1Department of Immunology and Allergy, Konya City Hospital, Konya, Turkey
Emel Atayik
1Department of Immunology and Allergy, Konya City Hospital, Konya, Turkey
Article usage
Posted January 31, 2022.
Are high urea values before intravenous immunoglobulin replacement a risk factor for COVID-related mortality?
Gökhan Aytekіn, Emel Atayik
medRxiv 2022.01.29.22270080; doi: https://doi.org/10.1101/2022.01.29.22270080
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (623)
- Anesthesia (162)
- Cardiovascular Medicine (2335)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11694)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3679)
- Geriatric Medicine (345)
- Health Economics (630)
- Health Informatics (2361)
- Health Policy (925)
- Hematology (339)
- HIV/AIDS (772)
- Medical Education (363)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3436)
- Nursing (194)
- Nutrition (519)
- Oncology (1800)
- Ophthalmology (533)
- Orthopedics (216)
- Otolaryngology (285)
- Pain Medicine (230)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6083)
- Radiology and Imaging (1254)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)